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Abstract
Multicentric Castleman’s disease is a polyclonal lymphoproliferative disorder. Recently, a new variant of the disease
was reported and named TAFRO syndrome, an acronym for thrombocytopenia, ascites, myelofibrosis, renal
dysfunction, and organomegaly. A 55-year-old woman presented to our hospital with dyspnea on exertion and
high fever. Laboratory tests revealed anemia, thrombocytopenia, and proteinuria. Computed tomography (CT)
revealed a large anterior mediastinal mass, mild splenomegaly, bilateral pleural effusion, pericardial effusion, and
mild systemic lymphadenopathy. A CT-guided biopsy was unable to establish a definitive diagnosis, so we resected
the mediastinal mass for diagnostic and therapeutic purposes. Pathological findings were consistent with the
hyaline vascular type of Castleman’s disease (CD), and she was diagnosed with TAFRO syndrome. There has been
no description of a patient with TAFRO syndrome with a large mass, and this is the first case of TAFRO syndrome
treated with debulking surgery.
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Background
Castleman’s disease (CD) is a rare, non-neoplastic lym-
phoproliferative disorder first reported in 1956 [1]. Mul-
ticentric Castleman’s disease (MCD) is a CD subtype
with multiple lesions and systemic symptoms that in-
cludes a heterogeneous group of disorders with various
etiologies. A new disease entity—TAFRO syndrome—has
been proposed as a rare variant of MCD [2], which poses
serious diagnostic and therapeutic challenges because its
precise pathophysiology remains unknown.
Case presentation
A 55-year-old Japanese woman was referred to our hos-
pital with dyspnea on exertion and high fever for
2 weeks. She had a rapid weight gain from 60 to 80 kg
in a month and severe anasarca. Laboratory tests re-
vealed anemia, thrombocytopenia, proteinuria, and ele-
vated levels of serum C-reactive protein, alkaline
phosphatase, and interleukin-6. She tested negative for
the human immunodeficiency virus (HIV), Epstein–Barr
virus, and human herpesvirus-8 (HHV-8) but positive for
platelet-associated immunoglobulin G and had a positive
direct Coombs test. Computed tomography (CT) revealed
a large anterior mediastinal mass, mild splenomegaly, bilat-
eral pleural effusion, pericardial effusion, and mild systemic
lymphadenopathy (Fig. 1). Bone marrow examination
showed normal cellularity but mild myelofibrosis. A CT-
guided biopsy of the mediastinal mass was unable to estab-
lish a definitive diagnosis, showing only severe fibrosis with
a few spindle cells. Despite treatment with all types of di-
uretics, including furosemide, tolvaptan, and eplerenone,
her medical condition deteriorated. Therefore, we decided
to resect the mediastinal mass for diagnostic and thera-
peutic purposes, considering the possibility of a paraneo-
plastic syndrome due to the mediastinal mass. A complete
resection of the mass via median sternotomy was per-
formed with concomitant resection of the pericardium and
left brachiocephalic vein, which were tightly adhered to the
mass (Fig. 2a). Histological and immunohistochemical find-
ings revealed that the mass was composed of collagenous
fibrous tissue with scattered lymph nodes, and hyperplasia
of lymphoid follicles was seen in the lymph nodes (Fig. 2b).
The lymphoid follicles were surrounded by a broad mantle
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zone composed of concentric rings of small lymphocytes
and the germinal centers exhibited hyalinized vascular pro-
liferation (Fig. 2c). These pathological findings were con-
sistent with the hyaline vascular type of CD.
She had an uneventful recovery from surgery and re-
quired limited diuretic therapy. Three months after sur-
gery, she showed a drastic weight loss from 80 to 55 kg
and her anemia and thrombocytopenia had resolved. A
chest roentgenogram taken at that time point showed no
pleural effusion or cardiac enlargement (Fig. 3). However,
half a year after surgery, she had rapid weight gain and bi-
lateral ascites. Laboratory tests showed a sharp decrease in
hemoglobin and platelets. 18F-fluorodeoxyglucose positron
emission tomography (FDG-PET)/CT imaging showed
higher FDG uptake in the bilateral cervical and supraclavi-
cular lymph nodes (Fig. 4). Excisional biopsy of the cer-
vical lymph node revealed the histological diagnosis of
hyaline vascular type CD. Finally, she was diagnosed with
TAFRO syndrome based on the laboratory tests, clinical
features, and pathological findings. She was admitted to
the hematology department of our hospital and received
corticosteroid pulse therapy with methylprednisolone. She
recovered smoothly and maintained a stable condition
with oral corticosteroids 1 year after surgery.
CD cases are pathologically classified into three types:
hyaline vascular, plasma cell, and mixed [3]. Unicentric
CD is often asymptomatic and associated with the hyaline
vascular histological type. However, MCD often
demonstrates episodic systemic inflammatory symptoms
and multiple organ impairment due to excessive proin-
flammatory cytokines, such as interleukin-6 [4]. The diag-
nosis of MCD is established when histopathological lymph
node features of CD and clinical features are observed.
Therefore, MCD describes a heterogeneous group of dis-
orders with various etiologies [5].
The HHV-8 and HIV infections are a well-established
cause of hypercytokinemia in MCD patients with plasma
cell histology [6]. However, a group of HIV-negative and
HHV-8 negative MCD cases has been reported [7] and
defined as idiopathic MCD [5]. Idiopathic MCD patho-
genesis is poorly understood, but polyneuropathy, orga-
nomegaly, endocrinopathy, monoclonal gammopathy,
and skin changes (POEMS syndrome), paraneoplastic
syndromes, and secretion of other cytokines by malig-
nant plasma cells have been reported to co-occur with
idiopathic MCD [5].
The histopathological and systemic features in idio-
pathic MCD are thought to be secondary to hypercytoki-
nemia caused by these diseases, and the new disease
concept of TAFRO syndrome was recently proposed in
Japan as a unique clinicopathological variant of idiopathic
MCD. TAFRO syndrome was described in a group of idio-
pathic MCD patients with thrombocytopenia, ascites, my-
elofibrosis, renal dysfunction, and organomegaly [2]. This
syndrome also demonstrates milder lymphadenopathy,
mixed or hyaline vascular histopathology, normal or mildly
Fig 1 a Chest computed tomography demonstrating an anterior mediastinal mass measuring 65 × 35 mm, bilateral pleural effusion, and b mild
peripheral lymphadenopathy
Fig 2 a The resected specimen reveals a grayish white tumor that tightly adhered to the left brachiocephalic vein and the pericardium. b Pathologic
findings of the resected specimen show collagenous fibrous tissue with scattered lymph follicles (hematoxylin and eosin stain, original magnification ×10).
c The lymphoid follicles were surrounded by a broad mantle zone composed of concentric rings of small lymphocytes and the germinal centers
exhibited hyalinized vascular proliferation (hematoxylin and eosin stain, original magnification ×100)
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elevated levels of interleukin-6, presence of autoantibodies,
severe anasarca, and normal immunoglobulin levels. The
clinical and pathological features in our case were compat-
ible with TAFRO syndrome, but there has been no de-
scription of a patient with TAFRO syndrome with a large
mass. This is then the first case of TAFRO syndrome with
a large anterior mediastinal mass.
Treatment strategies differ for unicentric CD and MCD.
Although surgery is the gold-standard treatment for uni-
centric CD presenting at any organ, the combination of
surgery and medical therapy is often used in MCD pa-
tients [8]. Three medical treatment strategies have been
used in MCD patients with TAFRO syndrome: anti-
inflammatory and immunosuppressive therapies such as
corticosteroids and cyclosporine A, cytotoxic elimination
of cells responsible for hypercytokinemia with cyclophos-
phamide and doxorubicin, and blockade of interleukin-6
signaling with monoclonal antibodies such as tocilizumab
[5]. Surgery in MCD patients is performed to obtain tissue
for a full histopathological diagnosis because sufficient
specimens of lymph nodes or solid organs are required for
a histopathological analysis of CD. The other role of sur-
gery in MCD patients is for debulking, i.e., to excise the
majority of the tissues affected by the disease. No long-
term survival difference in MCD patients treated with
debulking surgery, immunosuppressive therapy, or a com-
bination of both has been demonstrated, suggesting that
debulking surgery could be potentially beneficial for the
treatment of MCD [8]. Here, mediastinal tumor resection
was effective to improve the patient’s symptoms for
6 months. Although TAFRO syndrome may require sys-
temic therapy in the long term, debulking surgery for pa-
tients with TAFRO syndrome with a main tumor is
thought to be very useful in terms of both diagnosis and
treatment.
Conclusions
In conclusion, we describe the first case of a patient with
TAFRO syndrome with a large anterior mediastinal mass.
The surgical approach was very beneficial in terms of
diagnosis and treatment because it enabled us to confirm
the TAFRO syndrome and transiently control disease pro-
gression with a resection of the large mediastinal mass.
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